We read the article entitled ''Increased Mean Platelet Volume in Hypertrophic Cardiomyopathy'' by Icli et al 1 with interest. These authors stated that increased mean platelet volume (MPV) values might indicate altered platelet reactivity in patients with hypertrophic cardiomyopathy (HCM). The left ventricular outflow tract (LVOT) obstruction was also associated with MPV values. Thus, patients with HCM may need more aggressive antiplatelet therapy, especially those with hypertrophic obstructive cardiomyopathy.
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A single-center study like this 1 deserves appreciation, but there are some questions. First, the authors 1 stated that thromboembolic events might occur in patients with HCM, and an increased MPV could predict them. The MPV reflects platelet size and activation, and larger platelets are enzymatically more active and have higher thrombotic potential. [2] [3] [4] To assess the thrombotic potential of MPV as a marker, the patients should have been followed for longer time.
There is a caveat for the multivariate analysis. The authors 1 stated in the correlation analysis that MPV was significantly correlated with LVOT obstruction and septal thickness, and of the 2 variables, septal thickness (b ¼ .07, 95% CI: 0.04-0.09, P ¼ .001) was independently associated with MPV in linear regression analysis. The ''coefficient b'' is too low in the regression analysis so is it possible that the coefficient b is written incorrectly?
In the present study, 1 left atrium (LA) diameter was 42.7 + 4.1 mm in patients with HCM. Despite this result, the lack of atrial fibrillation is thought provoking. Thereafter, the question ''Do thromboembolic events increase in patients having HCM with sinus rhythm?'' comes to mind. In addition, the authors 1 did not clearly reveal the relationship between MPV and LA enlargement. We think that the LA diameter should have been included in the multivariate analysis. Açikgöz et al found a positive correlation between MPV and LA diameter in patients with heart failure. 5 Ozkan et al also showed that MPV and LA diameter were independent predictors of ischemic stroke in patients with sinus rhythm. 6 Finally, based on the current results, the relationship between HCM and MPV has not been totally clarified. Longterm follow-up studies are needed.
